These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26972529)

  • 21. Regulation of postsynaptic function by the dementia-related ESCRT-III subunit CHMP2B.
    Chassefeyre R; Martínez-Hernández J; Bertaso F; Bouquier N; Blot B; Laporte M; Fraboulet S; Couté Y; Devoy A; Isaacs AM; Pernet-Gallay K; Sadoul R; Fagni L; Goldberg Y
    J Neurosci; 2015 Feb; 35(7):3155-73. PubMed ID: 25698751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma membrane.
    Bodon G; Chassefeyre R; Pernet-Gallay K; Martinelli N; Effantin G; Hulsik DL; Belly A; Goldberg Y; Chatellard-Causse C; Blot B; Schoehn G; Weissenhorn W; Sadoul R
    J Biol Chem; 2011 Nov; 286(46):40276-86. PubMed ID: 21926173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-muscle MYH10/myosin IIB recruits ESCRT-III to participate in autophagosome closure to maintain neuronal homeostasis.
    Jun YW; Lee S; Ban BK; Lee JA; Gao FB
    Autophagy; 2023 Jul; 19(7):2045-2061. PubMed ID: 36849436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference.
    Nielsen TT; Mizielinska S; Hasholt L; Isaacs AM; Nielsen JE;
    J Gene Med; 2012 Aug; 14(8):521-9. PubMed ID: 22786763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3.
    Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K
    Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3.
    Chandrasekaran A; Dittlau KS; Corsi GI; Haukedal H; Doncheva NT; Ramakrishna S; Ambardar S; Salcedo C; Schmidt SI; Zhang Y; Cirera S; Pihl M; Schmid B; Nielsen TT; Nielsen JE; Kolko M; Kobolák J; Dinnyés A; Hyttel P; Palakodeti D; Gorodkin J; Muddashetty RS; Meyer M; Aldana BI; Freude KK
    Stem Cell Reports; 2021 Nov; 16(11):2736-2751. PubMed ID: 34678206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
    Clayton EL; Milioto C; Muralidharan B; Norona FE; Edgar JR; Soriano A; Jafar-Nejad P; Rigo F; Collinge J; Isaacs AM
    Brain; 2018 Dec; 141(12):3428-3442. PubMed ID: 30496365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia.
    West RJ; Lu Y; Marie B; Gao FB; Sweeney ST
    J Cell Biol; 2015 Mar; 208(7):931-47. PubMed ID: 25800055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia.
    Lee JA; Gao FB
    J Neurosci; 2009 Jul; 29(26):8506-11. PubMed ID: 19571141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator.
    Shirai R; Cho M; Isogai M; Fukatsu S; Okabe M; Okawa M; Miyamoto Y; Torii T; Yamauchi J
    Neurol Int; 2023 Aug; 15(3):980-993. PubMed ID: 37606396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
    Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
    Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia.
    Ferrari R; Kapogiannis D; Huey ED; Grafman J; Hardy J; Momeni P
    Alzheimer Dis Assoc Disord; 2010; 24(4):397-401. PubMed ID: 20592581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory markers of CHMP2B-mediated frontotemporal dementia.
    Roos P; von Essen MR; Nielsen TT; Johannsen P; Stokholm J; Bie AS; Waldemar G; Simonsen AH; Heslegrave A; Zetterberg H; ; Sellebjerg F; Nielsen JE
    J Neuroimmunol; 2018 Nov; 324():136-142. PubMed ID: 30193769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of CHMP2B in frontotemporal dementia.
    Urwin H; Ghazi-Noori S; Collinge J; Isaacs A
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):208-12. PubMed ID: 19143633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.
    Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice.
    Ghazi-Noori S; Froud KE; Mizielinska S; Powell C; Smidak M; Fernandez de Marco M; O'Malley C; Farmer M; Parkinson N; Fisher EM; Asante EA; Brandner S; Collinge J; Isaacs AM
    Brain; 2012 Mar; 135(Pt 3):819-32. PubMed ID: 22366797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntaxin 13, a genetic modifier of mutant CHMP2B in frontotemporal dementia, is required for autophagosome maturation.
    Lu Y; Zhang Z; Sun D; Sweeney ST; Gao FB
    Mol Cell; 2013 Oct; 52(2):264-71. PubMed ID: 24095276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
    Rostgaard N; Roos P; Budtz-Jørgensen E; Johannsen P; Waldemar G; Nørremølle A; Lindquist SG; Gydesen S; Brown JM; Collinge J; Isaacs AM; ; Nielsen TT; Nielsen JE
    Neurobiol Aging; 2017 Nov; 59():221.e1-221.e7. PubMed ID: 28888721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B.
    Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK
    Stem Cell Res; 2016 Jul; 17(1):151-153. PubMed ID: 27558614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.